Blueprint 37 : Assistant Apps : regulated space
AI health assistant product
A health-support product with AI at its core: symptom triage guidance, care navigation, chronic-condition coaching, or clinical documentation for providers. The winning boundary: support, educate and navigate; never diagnose or treat. Provider-side products (documentation, intake) face less consumer risk and faster sales.
The business case
Who pays, and for what.
Healthcare providers and clinics
Per-seat/per-provider licenses
Consumers (in safe-lane products)
Subscriptions
Employers and insurers
Population-health programs
Model 1
Provider co-pilot
Documentation, intake and admin assistance for clinicians (safer, faster sale).
Model 2
Patient navigator
Triage guidance and navigation in the consumer lane, with clinical guardrails.
Monetization
- Provider licenses (per clinician per month)
- Enterprise health-system contracts
- Consumer subscriptions (safe-lane only)
- Reimbursed programs where applicable
The MVP
The smallest version that proves it.
01
Scope letter
A written care boundary (what the product never does), reviewed by clinical and legal counsel.
02
Clinical safety
Escalation paths, red-flag detection, human clinical oversight in the loop.
03
One workflow
Intake, documentation or coaching: one workflow to clinical-grade reliability.
Core features
- Red-flag detection with hard escalation to humans
- Structured intake and history gathering
- Documentation drafting for clinician review
- Care navigation (where to go, what to ask)
- Audit trails meeting medical-record standards
Example workflow
- 01Patient intake or clinician task captured
- 02Red-flag screen runs; anything concerning escalates immediately
- 03AI drafts (documentation, guidance within scope)
- 04Clinician reviews and owns everything released
- 05Safety events logged and reviewed weekly
Technical blueprint
How the system is architected.
- Interface
- Intelligence
- Data
- Operations
Interface
Provider console / patient app depending on model
Intelligence
Constrained LLMs with clinical guardrails; deterministic red-flag rules; no autonomous clinical decisions
Data
Health data under HIPAA/GDPR-health regimes: minimum necessary, encryption everywhere, audit logs
Operations
Clinical advisor on retainer; incident reporting; model changes go through clinical review
Suggested stack
Data requirements
- Clinical protocols and triage logic
- EHR integrations (provider path)
- Outcome and safety data
Integrations
Build stages
From idea to launched business.
- Boundary
- Compliance
- Pilot clinic
- Evidence
Typical venture-build sequence with Novistu
- 01
Boundary
Define scope, guardrails and clinical oversight with advisors.
3 to 4 weeks - 02
Compliance
HIPAA/GDPR-health architecture, BAAs, audit trails.
4 to 8 weeks - 03
Pilot clinic
One clinic, one workflow, weekly clinical review.
2 to 3 months - 04
Evidence
Time-saved and safety data; publish honestly; sell on references.
Ongoing
Hard-won warnings
Common mistakes.
- 01
Consumer symptom checkers without clinical guardrails: regulators, platforms and lawyers converge on these
- 02
Selling to health systems without security review readiness (months of it)
- 03
Underestimating integration: healthcare runs on EHRs that resist newcomers
Regulated space : read this first
- HIPAA (US) / GDPR health provisions (EU): BAAs, data minimization, audit
- Medical-device boundaries: some decision-support features trigger regulation (FDA/MDR)
- Clinical safety standards and incident reporting
This is educational context, not legal advice. Get professional counsel for your jurisdiction before launch.
Differentiation
Health AI divides into risky consumer toys and trusted clinical infrastructure. Products that respect the boundary, engineer clinical safety visibly, and integrate with real workflows become part of care delivery; everything else becomes a cautionary tale.
How Novistu fits
Venture build with clinical partners; Novistu has shipped computer-vision health products (Wellnix) and applies the same boundary discipline.
Founder questions.
Provider-side: clearer buyer, lower regulatory exposure, real budget. Consumer products need the strongest guardrails in software and acquire slowly.
Non-negotiable. Clinical advisors shape the boundary, review safety, and lend the credibility pilots require. Budget for it from day one.
Depends on what it does: triage and decision support can trigger FDA/MDR classification. Get a regulatory assessment of your specific scope before writing code.
Build this with Novistu.
Bring this blueprint to a free first call. We pressure-test it honestly, then scope the MVP that proves it.
First call free : honest about fit : no obligation